News

AddToAny

Google+ Facebook Twitter Twitter

HPV primary screening

Following a review of its delivery strategy, NHS England has agreed to begin a one-stage procurement process to reconfigure provider laboratories to support the roll-out of Human Papilloma Virus (HPV) primary screening into the NHS Cervical Cancer Screening Programme in England.

my ibms Microscopic of koilocyte cell criteria of hpv human papilloma virus infection pap smear shutterstock

In coming to this decision, NHS England has taken advice and support from the IBMS, the Royal College of Pathologists and the British Association for Cytopathology.

This decision, based upon learning from market engagement events held earlier this year, will see the procurement commence in November 2018.

To ensure the NHS Cervical Screening Programme continues to deliver a quality service to women during this period of change, NHS England will work with NHS Improvement to give all laboratories that meet the quality criteria the opportunity to implement HPV primary screening ahead of the start of the procurement process.

 

Image Credit | Shutterstock

Related Articles

3D human cell models

Medicines Discovery Catapult and the Medical Research Council Centre for Drug Safety Science at the University of Liverpool are collaborating.

Petition to ban sunbeds

A petition has been launched in the hope of persuading the government to ban commercial sunbeds in the UK.

My lab: cellular pathology

Consultant Cellular Pathologist Paul Cross gives a guided tour of his lab at the Queen Elizabeth Hospital, Gateshead Health NHS Foundation Trust.

Liquid biopsy advances

Scientists are making strides in developing liquid biopsies for brain tumours by detecting tumour DNA in the fluid from around the brain and spine.

Top